Suppr超能文献

[超声引导下经直肠前列腺穿刺活检在前列腺癌诊断中的阳性率]

[Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].

作者信息

Fernández González I, Ruiz Rubio J L, Llorente Abarca C, Aramburu González J A, Montes Díaz M J, Herrero Payo A, Sánchez Sánchez E, Berenguer Sánchez A

机构信息

Servicio de Anatomía Patológica, Hospital Universitario de Getafe, Madrid, España.

出版信息

Arch Esp Urol. 1995 Jul-Aug;48(6):587-94.

PMID:7544968
Abstract

OBJECTIVES

The present study analyzes the combination of digital rectal examination (DRE), prostate specific antigen (PSA), transrectal ultrasound (TRUS) and ultrasound-guided transrectal biopsy in the diagnosis of prostate cancer.

METHODS

115 of 224 patients (51.3%) were biopsied due to a suspicious DRE and/or PSA > 4 ng/ml, and/or DPSA > 0.15, and/or the presence of a hypoechoic lesion on TRUS.

RESULTS

Adenocarcinoma of the prostate was diagnosed in 28 (24.3%) of these 115 patients. The positive predictive value (PPV) for carcinoma of the prostate was 4.76% if PSA was < 4 ng/ml, 5.12% if PSA was 4.1 to 10 ng/ml, and 48% if PSA was > 10 ng/ml. If DPSA is considered, the PPV is 7.4% if PSA is 4.1 to 10 ng/ml and 51.02% if PSA is > 10 ng/ml. If DRE is suspicious, the PPV is 43.6%, with a sensitivity of 85.7% and a specificity of 63.9%. The PPV for carcinoma of the prostate was 34% for a hypoechoic lesion on TRUS, 50% if DRE is suspicious, 53.5% is PSA is > 10 ng/ml and 65% if DRE is suspicious and PSA > 10 ng/ml.

CONCLUSIONS

The detection rate of carcinoma of the prostate is increased when DRE, PSA, TRUS and US-guided transrectal biopsy are used in combination.

摘要

目的

本研究分析直肠指检(DRE)、前列腺特异性抗原(PSA)、经直肠超声(TRUS)及超声引导下经直肠活检联合应用在前列腺癌诊断中的价值。

方法

224例患者中,115例(51.3%)因DRE可疑和/或PSA>4 ng/ml,和/或游离PSA(DPSA)>0.15,和/或TRUS发现低回声病变而行活检。

结果

这115例患者中28例(24.3%)诊断为前列腺腺癌。PSA<4 ng/ml时前列腺癌的阳性预测值(PPV)为4.76%,PSA为4.1至10 ng/ml时为5.12%,PSA>10 ng/ml时为48%。若考虑DPSA,PSA为4.1至10 ng/ml时PPV为7.4%,PSA>10 ng/ml时为51.02%。若DRE可疑,PPV为43.6%,敏感性为85.7%,特异性为63.9%。TRUS发现低回声病变时前列腺癌的PPV为34%,DRE可疑时为50%,PSA>10 ng/ml时为53.5%,DRE可疑且PSA>10 ng/ml时为65%。

结论

联合应用DRE、PSA、TRUS及超声引导下经直肠活检可提高前列腺癌的检出率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验